{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:04:39Z","timestamp":1767135879559,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd010729","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,12,18]],"date-time":"2014-12-18T00:00:00Z","timestamp":1418860800000}}],"reference-count":77,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010729.pub2","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T02:36:43Z","timestamp":1418956603000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Beh\u00e7et's Syndrome"],"prefix":"10.1002","volume":"2014","author":[{"given":"Francesca","family":"Nava","sequence":"first","affiliation":[{"name":"University of Milano-Bicocca; Faculty of Statistical Science; via Bicocca degli Arcimboldi 8 Milan Italy 20126"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ghilotti","sequence":"additional","affiliation":[{"name":"University of Milano-Bicocca; Faculty of Statistical Science; via Bicocca degli Arcimboldi 8 Milan Italy 20126"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[{"name":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; Neurology IV- Neuro-Immunology and Neuromuscular Diseases; Via Celoria, 11 Milano Italy 20133"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulen","family":"Hatemi","sequence":"additional","affiliation":[{"name":"Istanbul University, Cerrahpasa Medical School; Department of Internal Medicine, Division of Rheumatology; Cerrahpasa Tip Fakultesi, Aksaray Istanbul Turkey 34365"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Del Bianco","sequence":"additional","affiliation":[{"name":"AOUP; Department of Rheumatology; Via Roma Pisa Italy 56126"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Merlo","sequence":"additional","affiliation":[{"name":"Fondazione Marchi; Ospedale Di Circolo Del Ponte; Via Del Ponte, 19 Varese Varese Italy 21040"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziella","family":"Filippini","sequence":"additional","affiliation":[{"name":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; Scientific Direction; via Celoria, 11 Milano Italy 20133"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Tramacere","sequence":"additional","affiliation":[{"name":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; Neuroepidemiology Unit; Via Giovanni Celoria, 11 Milano Italy 20133"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,12,18]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD010729.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archneur.1996.00550070133022","article-title":"Seven-year follow-up of neurologic involvement in Beh\u00e7et syndrome","volume":"53","author":"Akman-Demir","year":"1996","journal-title":"Archives of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD010729.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0035-3787(06)75121-9","article-title":"Neurological involvement in Beh\u00e7et's disease, 154 cases from a cohort of 925 patients and review of the literature","volume":"162","author":"Benamour","year":"2006","journal-title":"Revue Neurologique"},{"issue":"6","key":"10.1002\/14651858.CD010729.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10067-010-1650-9","article-title":"MRI findings of neuro-Behcet's disease","volume":"30","author":"Borhani Haghighi","year":"2011","journal-title":"Clinical Rheumatology"},{"issue":"8","key":"10.1002\/14651858.CD010729.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/art.34450","article-title":"Immunosuppressants reduce venous thrombosis relapse in Beh\u00e7et's disease","volume":"64","author":"Desbois","year":"2012","journal-title":"Arthritis and Rheumatism"},{"issue":"1-2","key":"10.1002\/14651858.CD010729.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.07.053","article-title":"Epilepsy and Beh\u00e7et's disease: cortical and hippocampal involvement in Brazilian patients","volume":"309","author":"Dutra","year":"2011","journal-title":"Journal of the Neurological Sciences"},{"issue":"8-9","key":"10.1002\/14651858.CD010729.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.neurol.2010.03.004","article-title":"Neurological involvement in Beh\u00e7et's disease: evaluation of 67 patients","volume":"166","author":"Essaadouni","year":"2010","journal-title":"Revue Neurologique"},{"issue":"3","key":"10.1002\/14651858.CD010729.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.64.3.382","article-title":"Beh\u00e7et's syndrome: a report of 41 patients with emphasis on neurological manifestations","volume":"64","author":"Farah","year":"1998","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD010729.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s00415-010-5454-2","article-title":"Neurological manifestations of Beh\u00e7et's disease in Japan: a study of 54 patients","volume":"257","author":"Ideguchi","year":"2010","journal-title":"Journal of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD010729.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3899\/jrheum.100257","article-title":"Pediatric Behcet's disease and thromboses","volume":"38","author":"Krupa","year":"2011","journal-title":"Journal of Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD010729.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/art.24393","article-title":"Cerebral venous thrombosis in Beh\u00e7et's disease","volume":"61","author":"Saadoun","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/0-306-48382-3_75","article-title":"Neuro-Beh\u00e7et's disease (isolated cerebral thrombophlebitis excluded). Clinical pattern, prognostic factors, treatment and long term follow-up","volume":"528","author":"Sbai","year":"2003","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"3","key":"10.1002\/14651858.CD010729.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archneur.1989.00520390031011","article-title":"Neurologic involvement in Beh\u00e7et's syndrome. A prospective study","volume":"46","author":"Serdaro\u011flu","year":"1989","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD010729.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.lpm.2008.04.015","article-title":"Neurological manifestations of Behcet's disease: 22 cases among 170 patients","volume":"38","author":"Tohm\u00e9","year":"2009","journal-title":"Presse M\u00e9dicale"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD010729.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1212\/WNL.42.3.614","article-title":"Cerebral venous thrombosis in Beh\u00e7et's disease: clinical study and long-term follow-up of 25 cases","volume":"42","author":"Wechsler","year":"1992","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD010729.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/qjmed\/92.12.727","article-title":"Beh\u00e7et's syndrome: a multidisciplinary approach to clinical care","volume":"92","author":"Whallett","year":"1999","journal-title":"QJM: monthly journal of the Association of Physicians"},{"issue":"7","key":"10.1002\/14651858.CD010729.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-1331.2007.01754.x","article-title":"Clinical characteristics and course of spinal cord involvement in Beh\u00e7et's disease","volume":"14","author":"Yesilot","year":"2007","journal-title":"European Journal of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD010729.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s00415-009-5088-4","article-title":"Cerebral venous thrombosis in Beh\u00e7et's disease compared to those associated with other etiologies","volume":"256","author":"Yesilot","year":"2009","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0018|cit18","volume-title":"Basic Immunology: Functions and Disorders of the Immune System","author":"Abbas","year":"2001"},{"issue":"3","key":"10.1002\/14651858.CD010729.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/ar3043","article-title":"Phenotype and functional changes of V\u03b39\/V\u03b42 T lymphocytes in Behcet\u2019s disease and the effect of in\ufb02iximab on V\u03b39\/V\u03b42 T cell expansion, activation and cytotoxicity","volume":"12","author":"Accardo-Palumbo","year":"2010","journal-title":"Arthritis Research & Therapy"},{"issue":"4","key":"10.1002\/14651858.CD010729.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neurol.2011.09.006","article-title":"Neurological manifestations of Beh\u00e7et's disease: evaluation of 40 patients treated by cyclophosphamide","volume":"168","author":"Ait Ben Haddou","year":"2012","journal-title":"Revue Neurologique (Paris)"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Beh\u00e7et\u2019s disease: evaluation of 200 patients","volume":"122","author":"Akman-Demir","year":"1999","journal-title":"Brain"},{"issue":"4 Suppl 50","key":"10.1002\/14651858.CD010729.pub2-BIB0022|cit22","first-page":"S84","article-title":"Cyclosporine for Beh\u00e7et's uveitis: is it associated with an increased risk of neurological involvement?","volume":"26","author":"Akman-Demir","year":"2008","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD010729.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","article-title":"Neuro-Beh\u00e7et's disease: epidemiology, clinical characteristics, and management","volume":"8","author":"Al-Araji","year":"2009","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-510X(99)00165-3","article-title":"Neuro-Behcet's disease in Iraq: a study of 40 patients","volume":"170","author":"Al-Fahad","year":"1999","journal-title":"Journal of the Neurology Sciences"},{"issue":"3","key":"10.1002\/14651858.CD010729.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clineuro.2006.11.002","article-title":"A patient with neuro-Beh\u00e7et's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade","volume":"109","author":"Alty","year":"2007","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"1","key":"10.1002\/14651858.CD010729.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","article-title":"Anti-TNF agents for Behcet\u2019s disease: analysis of published data on 369 patients","volume":"41","author":"Arida","year":"2011","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD010729.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1756285609347123","article-title":"Diagnosis and treatment of cerebral vasculitis","volume":"3","author":"Berlit","year":"2010","journal-title":"Therapeutic Advances in Neurological Disorders"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/art.24423","article-title":"Epidemiology and clinical characteristics of Beh\u00e7et's disease in the US: a population-based study","volume":"61","author":"Calamia","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0029|cit29","unstructured":"Cancer Therapy Evaluation Program Common terminology criteria for adverse event www.ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3to2.pdf"},{"issue":"17","key":"10.1002\/14651858.CD010729.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2165\/11641370-000000000-00000","article-title":"Behcet's Syndrome","volume":"72","author":"Dalvi","year":"2012","journal-title":"Drugs"},{"issue":"3","key":"10.1002\/14651858.CD010729.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1756-185X.2010.01546.x","article-title":"Rituximab in intractable ocular lesions of Behcet\u2019s disease; randomized single-blind control study (pilot study)","volume":"13","author":"Davatchi","year":"2010","journal-title":"International Journal of Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0032|cit32","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD010729.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2125.2011.03958.x","article-title":"Rilonacept and canakinumab","volume":"71","author":"Dubois","year":"2011","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"1-2","key":"10.1002\/14651858.CD010729.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jneuroim.2011.08.014","article-title":"Infliximab monotherapy in neuro-Beh\u00e7et's disease: four year follow-up in a long-standing case resistant to conventional therapies","volume":"239","author":"Fasano","year":"2011","journal-title":"Journal of Neuroimmunology"},{"issue":"1","key":"10.1002\/14651858.CD010729.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00296-009-1213-z","article-title":"One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Beh\u00e7et's disease refractory to standard immunosuppressive drugs","volume":"31","author":"Giardina","year":"2011","journal-title":"Rheumatology International"},{"issue":"5","key":"10.1002\/14651858.CD010729.pub2-BIB0037|cit37","first-page":"931","article-title":"Development of the BD-QoL: a quality of life measure specific to Beh\u00e7et's disease","volume":"31","author":"Gilworth","year":"2004","journal-title":"Journal of Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD010729.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/09273948.2011.634978","article-title":"HLA-B*51 and Beh\u00e7et Disease","volume":"20","author":"G\u00fcl","year":"2012","journal-title":"Ocular Immunology and Inflammation"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","article-title":"EULAR recommendations for the management of Beh\u00e7et disease","volume":"67","author":"Hatemi","year":"2008","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3 Suppl 72","key":"10.1002\/14651858.CD010729.pub2-BIB0040|cit40","first-page":"80","article-title":"Beh\u00e7et's syndrome: a critical digest of the recent literature","volume":"30","author":"Hatemi","year":"2012","journal-title":"Clinical Experimental Rheumatology"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0041|cit41","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD010729.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-510X(98)00165-8","article-title":"Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease","volume":"159","author":"Hirohata","year":"1998","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD010729.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107.","article-title":"The International Criteria for Beh\u00e7et's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","author":"Davatchi","year":"2014","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0044|cit44","first-page":"1078","article-title":"Criteria for diagnosis of Behcet's disease","volume":"355","author":"International Study Group for Behcet's disease","year":"1990","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD010729.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","article-title":"Diagnosis and management of neuro-Beh\u00e7et's disease: international consensus recommendations","volume":"261","author":"Kalra","year":"2014","journal-title":"Journal of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD010729.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1442-9071.2001.00445.x","article-title":"Central nervous system symptoms in a population of Beh\u00e7et's disease patients with refractory uveitis treated with cyclosporine A","volume":"29","author":"Kato","year":"2001","journal-title":"Clinical and Experimental Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD010729.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"7681","DOI":"10.1167\/iovs.11-7999","article-title":"Effect of in\ufb02iximab on gene expression pro\ufb01ling in Behcet\u2019s disease","volume":"52","author":"Keino","year":"2011","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/brain\/122.11.2183","article-title":"Neurological complications of Behcet's syndrome","volume":"122","author":"Kidd","year":"1999","journal-title":"Brain"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/0-306-48382-3_117","article-title":"Low dose MTX for progressive neuro-Beh\u00e7et's disease. A follow-up study for 4 years","volume":"528","author":"Kikuchi","year":"2003","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0050|cit50","unstructured":"Kose O Development of immunopathogenesis strategies to treat Behcet\u2019s disease Pathology Research International"},{"issue":"3","key":"10.1002\/14651858.CD010729.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0161-6420(99)90120-3","article-title":"Central nervous system symptoms in patients with Beh\u00e7et disease receiving cyclosporine therapy","volume":"106","author":"Kotake","year":"1999","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD010729.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of Beh\u00e7et syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010729.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s10067-005-0070-8","article-title":"CNS involvement occurs more frequently in patients with Beh\u00e7et's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases","volume":"25","author":"K\u00f6tter","year":"2006","journal-title":"Clinical Rheumatology"},{"issue":"4 Suppl 60","key":"10.1002\/14651858.CD010729.pub2-BIB0054|cit54","first-page":"S102","article-title":"Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab","volume":"28","author":"Leccese","year":"2010","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/rheumatology\/kei165","article-title":"A double-blind trial of depot corticosteroids in Behcet\u2019s syndrome","volume":"45","author":"Mat","year":"2006","journal-title":"Rheumatology (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD010729.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00041327-200106000-00011","article-title":"Interferon-alpha 2a treatment of neuro-Behcet disease","volume":"21","author":"Nichols","year":"2001","journal-title":"Journal of Neuro-opthalmology"},{"issue":"1","key":"10.1002\/14651858.CD010729.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0002-9343(84)90753-8","article-title":"Chlorambucil in the treatment of uveitis and meningoencephalitis of Beh\u00e7et's disease","volume":"76","author":"O'Duffy","year":"1984","journal-title":"American Journal of Medicine"},{"issue":"4 Suppl 67","key":"10.1002\/14651858.CD010729.pub2-BIB0058|cit58","first-page":"S54","article-title":"Efficacy of adalimumab in patients with Beh\u00e7et's disease unsuccessfully treated with infliximab","volume":"29","author":"Olivieri","year":"2011","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD010729.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/art.23345","article-title":"Infliximab for the treatment of Neuro-Beh\u00e7et's disease: a cases eries and review of the literature","volume":"59","author":"Pipitone","year":"2008","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0060|cit60","unstructured":"Reeves BC Deeks JJ Higgins JPT Wells GA Chapter 13: Including non-randomized studies. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0061|cit61","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD010729.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001084","article-title":"Pharmacotherapy for Behcet's syndrome","author":"Saenz","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/art.22500","article-title":"Epidemiology and clinical course of Beh\u00e7et's disease in the Reggio Emilia area of northern Italy: a seventeen-year population-based study","volume":"57","author":"Salvarani","year":"2007","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD010729.pub2-BIB0064|cit64","first-page":"181","article-title":"Successful treatment of long-standing neuro-Beh\u00e7et's disease with infliximab","volume":"32","author":"Sarwar","year":"2005","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0065|cit65","article-title":"Presenting results and \u2018Summary of \ufb01ndings\u2019 tables","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2011"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0066|cit66","article-title":"Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2011"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004150050205","article-title":"Beh\u00e7et\u2019s disease and the nervous system","volume":"245","author":"Serdaroglu","year":"1998","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010729.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clineuro.2011.10.024","article-title":"Tocilizumab treatment for neuro-Behcet's disease, the first report","volume":"114","author":"Shapiro","year":"2012","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"4 Suppl 67","key":"10.1002\/14651858.CD010729.pub2-BIB0069|cit69","first-page":"S64","article-title":"Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Beh\u00e7et's disease with parenchymal involvement: presentation of four cases","volume":"29","author":"Shugaiv","year":"2011","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD010729.pub2-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","author":"Singh","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004150170242","article-title":"Beh\u00e7et\u2019s disease: diagnostic and prognostic aspects of neurological involvement","volume":"248","author":"Siva","year":"2001","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0072|cit72","unstructured":"Sterne J Higgins J Reeves B Extending the risk of bias tool to allow for assessment of non-randomised studies, cluster-randomised trials and cross-over trials: a Cochrane methods innovation fund project. 21st Cochrane Colloquium, Quebec 19-23 September 2013 Available from www.cochrane.org\/features\/2013-cochrane-colloquium"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Beh\u00e7et disease: an analysis of 880 patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"American Journal of Ophthalmology"},{"issue":"21","key":"10.1002\/14651858.CD010729.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1212\/WNL.0b013e318238edeb","article-title":"Clinical characteristics of pediatric-onset neuro-Beh\u00e7et disease","volume":"77","author":"Uluduz","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD010729.pub2-BIB0075|cit75","first-page":"206","article-title":"The combined use of HLA-B5 and the pathergy test as diagnostic markers of Beh\u00e7et's disease in Turkey","volume":"7","author":"Yazici","year":"1980","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD010729.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12016-012-8319-x","article-title":"Beh\u00e7et syndrome: is it one condition?","volume":"43","author":"Yazici","year":"2012","journal-title":"Clinical Reviews in Allergy and Immunology"},{"key":"10.1002\/14651858.CD010729.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2014.01.014","article-title":"Criteria for Beh\u00e7et's disease with reflections on all disease criteria","volume":"48-49","author":"Yazici","year":"2014","journal-title":"Journal of Autoimmunity"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010729.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T06:59:21Z","timestamp":1698130761000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010729.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,18]]},"references-count":77,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010729.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,18]]}}}